Back to search

Aristotle University Of Thessaloniki (AUTH)

In vitro μελέτη της επίδρασης της quercetin στα κύτταρα της οξείας μυελογενούς λευχαιμίας

Abstract

dc:description

Acute myeloid leukemia (AML) at older age is associated with several biologic and clinical characteristics. Hence, it may arise from an early level of hematopoietic stem cells and has a high frequency of blast cells with multidrug resistance glycoprotein MDR1 expression and particularly a high incidence of poor prognostic karyotypes. These factors, rather than age per se, underlie the poorer outcome as compared with younger cases. Therefore, new treatment strategies need to be developed. Today, flavonoids receive the greatest attention as potent anticancer agents. Quercetin (3, 3', 4', 5, 7- pentahydroxyflavone), a common component of our diet, is one of the most studied flavonoids due to its potent antiproliferative effect and ability to induce apoptosis in cancer cell lines. The induction of programmed cell death also known as apoptosis, is the common outcome of successful cytotoxic therapy for many different types of cancer, including AML. Multiple genetic alterations that result in the disruption of the physiological regulation of apoptosis are thought to account for the ability of leukemic cells to grow autonomously and for their clinical resistance to therapy. Recently, a new family of downstream inhibitors of caspases, the IAP (inhibitor of apoptosis protein) family, has emerged as a potential key player in the regulation of apoptosis in cancer. Survivin is a member of the IAP family and a bifunctional protein that suppresses apoptosis and regulates cell division. This protein has garnered great interest as a potential drug target because its expression is among the most tumor-specific of all human gene products. While fetal tissues contain abundant survivin mRNA and protein, most normal adult tissues do not. In contrast, the vast majority of tumors express survivin protein at high levels, suggesting that reactivation of SURVIVIN gene expression occurs commonly in cancers. The aim of this study is to investigate in vitro the effect of quercetin on viability, growth and apoptosis of AML cells from elderly patients, as well as to find out if and how the expression of antiapoptotic protein survivin is affected. For this reason we used long term bone marrow cultures (LTBMCs) from AML patients, where leukemic cells were grown without (control cultures) and with the addition of quercetin at doses of 50 μΜ and 100 μΜ in various time points (24, 48, 72 hours and 1 week). Cell viability was evaluated by double counting of trypan blue dye-excluding cells under a light microscope and cells counts were performed with a hemocytometer. Apoptosis was determined by the use of annexin V expression. Intracellular staining with anti-human survivin monoclonal antibody was used to detect survivin protein. Apoptosis and survivin expression were estimated using flow cytometry after gating on blast population, on the basis of their low SS and CD45 dim staining. We also used short term bone marrow cultures, after quercetin addition on LTBMCs for 24 hours, in order to evaluate the effect of quercetin on progenitor cells. Twenty elderly AML patients (14 with de novo AML and 6 transformed from MDS) were included in this study. The patients (12 men and 8 women), over 60 years of age (mean age 68.8±9.2 years), were at initial stage of AML, without any prior treatment. According to FAB criteria the classification was Μ0: 1, Μ1: 3, Μ2: 8, Μ4: 4, Μ5: 3, Μ6:1. Our results showed: • Quercetin decreased the viability of leukemic cells in a dose and time dependent manner. • Quercetin inhibited the growth of leukemic cells in a dose and time dependent manner. • Quercetin increased apoptosis of leukemic cells in a dose and time dependent manner. • All the AML patients expressed the survivin protein. • Quercetin enhanced the expression of the antiapoptotic protein survivin in leukemic cells in a dose dependent • Quercetin decreased the number of colonies, especially at the dose of 100 μΜ. In conclusion, it is obvious from this study that although the mechanism of action of quercetin is not clear, it is certain that this substance promotes apoptosis of leukemic cells. Given that many chemotherapeutic agents act via apoptosis induction, it is possible that compounds such as quercetin would have greater antileukemic efficacy if combined with conventional cytotoxic chemotherapy.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kyriakopoulou, I.
  • Κυριακοπούλου, Ιωάννα

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19467

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kyriakopoulou, I.; Κυριακοπούλου, Ιωάννα. In vitro μελέτη της επίδρασης της quercetin στα κύτταρα της οξείας μυελογενούς λευχαιμίας. Aristotle University Of Thessaloniki (AUTH), 2008. http://hdl.handle.net/10442/hedi/19467